WEBCAST - Mayo Clinic Neuroscience and Oncology Innovation Summit 2017
Course Directors: William D. Freeman, M.D., Alfredo Quinones-Hinojosa, M.D., Joon H. Uhm, M.D., Betty Kim, M.D., Ph.D., Robert B. Diasio, M.D. and Asher A. Chanan-Khan, M.D.
Co-Course Directors: Christina Smith, A.R.N.P. and Suzanne Brown, B.S.N., C.N.R.N., S.C.R.N.
This course will provide attendees with an update in major areas of neuroscience and oncology research from basic science, translational laboratories and clinical trials research. Lectures will cover neuroscientific arenas including brain tumor biology and growth, vascular neogenesis, nanotechnology for tumor suppression, viral vectors for tumor destruction, and other new agents to target and destroy brain tumors. The conference will discuss basic tumors of the brain and other sites including breast in addition to metastatic brain tumor therapies. Also, the course will cover the latest diagnostic and therapeutic approaches to tumors. Lectures will be supplemented with high yield industry and CEO-level Q&A sessions, precision medicine, and patient and celebrity stories. Other high yield sessions will include governmental policy makers that are guiding brain tumor patient care for future health care systems.
Registration Fees: $425
Live Course
Four Seasons Resort Orlando at Walt Disney World® Resort
September 7-9, 2017
If you prefer to attend the course in-person, click here.
Exhibit Opportunities:
This course offers the unique opportunity for commercial companies to interact with health care providers and highlight their products and services. If you are interested in exhibit space during this course, please contact Florida Exhibits.
Target Audience
This course is designed for neurologists, neurosurgeons, medical oncologists, neuropathologists, neurointerventional surgeons, radiation oncologists, pathologists, ARNPs/PAs, nurses and other healthcare personnel who are interested in this field.
Learning Objectives
Upon conclusion of this program, participants should be able to:
- Recognize the signs and symptoms of cancer and primary and metastic brain tumors
- Define tumor biology of primary and metastatic brain tumors as well as new scientific methods to destroy and neutralize tumor growth
- Provide cutting-edge updates in neuroscience, neuro-oncology, and oncologic biology research
- Outline U.S. health challenges in patient care for the future of those with brain and other tumors and cancer
Attendance at this Mayo Clinic course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.
AMA
Mayo Clinic College of Medicine and Science is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Mayo Clinic College of Medicine and Science designates live activity for a maximum of 17.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
*Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AOA
This program has been accredited by the American Osteopathic Association for 17.25 credits of AOA Category 2-A.
Other Health Care Professionals
A certificate of attendance will be provided to other health care professionals for requesting credits in accordance with state nursing boards, specialty societies, or other professional associations.
Available Credit
- 18.00 AMA PRA Category 1 Credit™
Price
Cancellation and Refund Policy:
Request for cancellations must be submitted in writing to cme@mayo.edu. When cancelling a registration for a course 14 days or more before the course start date, a full refund (minus a $75 administrative fee) will be issued in the same form of payment the registration was received. No refunds are granted less than 14 days before the course start date.
Any use of this site constitutes your agreement to the Terms and Conditions of Online Registration.